- Status:
- Red
- Decision Date:
- July 2025
Comments
NICE TA1069 Efgartigimod for treating antibody-positive generalised myasthenia gravisRed Drug Classifications
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again